Royal Bank Of Canada Bausch Health Companies Inc. Transaction History

Royal Bank Of Canada

$458 Billion
Q1 2025

A detailed history of Royal Bank Of Canada transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 8,418,164 shares of BHC stock, worth $54.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,418,164

Previous 11,188,348 24.76%

Holding current value

$54.5 Million

Previous $90.2 Million 39.6%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$6.16 - $7.94 $17.1 Million - $22 Million	-2,770,184 Reduced 24.76%	8,418,164 $54.5 Million
Q4 2024 Feb 14, 2025	SELL	$7.34 - $9.78 $44,062 - $58,709	-6,003 Reduced 0.05%	11,188,348 $90.2 Million
Q3 2024 Nov 14, 2024	SELL	$5.22 - $8.26 $1.39 Million - $2.2 Million	-266,642 Reduced 2.33%	11,194,351 $91.2 Million
Q2 2024 Aug 14, 2024	SELL	$6.1 - $10.41 $1.56 Million - $2.66 Million	-255,052 Reduced 2.18%	11,460,993 $79.9 Million
Q1 2024 Nov 05, 2024	BUY	$7.77 - $10.61 $1.98 Million - $2.71 Million	255,052 Added 2.23%	11,716,045 $124 Million
Q1 2024 May 15, 2024	SELL	$7.77 - $10.61 $213,776 - $291,912	-27,513 Reduced 0.23%	11,716,045 $124 Million
Q4 2023 Feb 14, 2024	BUY	$6.53 - $8.23 $53.3 Million - $67.1 Million	8,154,938 Added 227.24%	11,743,558 $94.2 Million
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $18.6 Million - $23.5 Million	2,423,865 Added 208.1%	3,588,620 $29.5 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $419,687 - $645,673	73,372 Added 6.72%	1,164,755 $9.32 Million
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $134,969 - $211,696	-21,492 Reduced 1.93%	1,091,383 $8.84 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $4.5 Million - $5.86 Million	-739,219 Reduced 39.91%	1,112,875 $6.99 Million
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $1.38 Million - $2.77 Million	-301,127 Reduced 13.98%	1,852,094 $12.8 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $11.3 Million - $37.7 Million	-1,597,352 Reduced 42.59%	2,153,221 $18 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $13.6 Million - $17.5 Million	-630,926 Reduced 14.4%	3,750,573 $85.7 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $2.86 Million - $3.61 Million	-124,422 Reduced 2.76%	4,381,499 $121 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $1.12 Million - $1.34 Million	-44,731 Reduced 0.98%	4,505,921 $125 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $125 Million - $149 Million	4,550,652 New	4,550,652 $133 Million

Others Institutions Holding BHC

# of Institutions

269

Shares Held

243M

Call Options Held

3.66M

Put Options Held

11.3M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.34B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Bausch Health Companies Inc. Transaction History